Bio-Techne CorporationTECHNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank33
Year-over-Year Change
Year-over-year SG&A expense growth
Percentile
P33
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -2.17% |
| Q3 2025 | 400.57% |
| Q2 2025 | -84.65% |
| Q1 2025 | 24.55% |
| Q4 2024 | 1.92% |
| Q3 2024 | 97.02% |
| Q2 2024 | -45.92% |
| Q1 2024 | -3.31% |
| Q4 2023 | 9.81% |
| Q3 2023 | 73.20% |
| Q2 2023 | -38.72% |
| Q1 2023 | 6.70% |
| Q4 2022 | -6.41% |
| Q3 2022 | 58.08% |
| Q2 2022 | -29.58% |
| Q1 2022 | -11.35% |
| Q4 2021 | 16.85% |
| Q3 2021 | 66.96% |
| Q2 2021 | -37.51% |
| Q1 2021 | -0.63% |
| Q4 2020 | 14.49% |
| Q3 2020 | 93.47% |
| Q2 2020 | -43.42% |
| Q1 2020 | -2.52% |
| Q4 2019 | -1.42% |
| Q3 2019 | 0.40% |
| Q2 2019 | 5.80% |
| Q1 2019 | 2.15% |
| Q4 2018 | -5.14% |
| Q3 2018 | 2.70% |
| Q2 2018 | 22.52% |
| Q1 2018 | -16.45% |
| Q4 2017 | 9.41% |
| Q3 2017 | 23.50% |
| Q2 2017 | -1.89% |
| Q1 2017 | -13.56% |
| Q4 2016 | 20.30% |
| Q3 2016 | 21.63% |
| Q2 2016 | 8.01% |
| Q1 2016 | 1.83% |